When it comes to breast cancer treatment, making informed decisions is crucial, and that's where the EndoPredict test comes in.
The EndoPredict test is a groundbreaking genomic test designed to determine the most appropriate treatment strategies for breast cancer patients. It provides personalized information about the likelihood of cancer recurrence and the potential benefits of chemotherapy. The EndoPredict test provides physicians with vital insights to tailor treatment plans to individual patients.
At Agiomix, we aim to empower individuals with comprehensive information about the EndoPredict test and its impact on breast cancer treatment. Empower yourself with knowledge and take control of your breast cancer treatment decisions with the EndoPredict test.
Trust Agiomix and EndoPredict for accurate, prognostic breast cancer testing that you can rely on.
Optimize & Individualize Breast Cancer Treatment!
Agiomix has partnered with Endopredict® to be able to provide the most accurate second-generation Breast Cancer prognostic test in the MENA region. The test is proven to predict each patient’s risk of early and long-term breast cancer recurrence that can help avoid over and under-treatment of breast cancer.
Agiomix proudly offers Endopredict in the MENA region.
For more information and to request the test, please contact us at [email protected]
Testing Process
